Better Therapeutics
(OTC) BTTX
Better Therapeutics Financials at a Glance
Market Cap
$5,400
Revenue (TTM)
$0.00
Net Income (TTM)
$31.57M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-16.60 (Low)
Dividend
$0.00
Beta (Volatility)
-16.60 (Low)
Price
$0.00
Volume
34
Open
$0.00
Price
$0.00
Volume
34
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Dividend
$0.00
Beta (Volatility)
-16.60 (Low)
Price
$0.00
Volume
34
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
BTTX News
BTTX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Better Therapeutics
Industry
Health Care Technology
Sector
Health CareEmployees
54
CEO
Frank L. Karbe, MBA
Website
www.bettertx.comHeadquarters
San Francisco, CA 94104, US
BTTX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
-4%
Return on Assets
-2%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$5.40K
Shares Outstanding
54.35M
Volume
34
Short Interest
0.00%
Avg. Volume
11.75K
Financials (TTM)
Gross Profit
$2.73M
Operating Income
$38.26M
EBITDA
$38.21M
Operating Cash Flow
$28.93M
Capital Expenditure
$1.18M
Free Cash Flow
$30.11M
Cash & ST Invst.
$15.74M
Total Debt
$14.88M
Better Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$841.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$5.40K
N/A
Market Cap/Employee
$100.00
N/A
Employees
54
N/A
Net Income
$5.86M
+48.6%
EBITDA
$4.50M
+56.3%
Quarterly Fundamentals
Net Cash
$7.71M
-202.5%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$7.72M
-33.8%
Short Term Debt
$6.59M
+110.5%
Return on Assets
-1.73%
N/A
Return on Invested Capital
-4.05%
N/A
Free Cash Flow
$5.95M
+19.5%
Operating Cash Flow
$5.94M
+15.2%